Skip to main content
Staff Login
Username
*
Enter your The Contraceptive Pipeline Database username.
Password
*
Enter the password that accompanies your username.
Log in
Forgot password
Toggle navigation
SIPPR LNG IUS
Product Overview
Development Status:
Active Development
Target:
Female
Mode:
Hormonal
Delivery Type:
Intrauterine
Duration Type:
Long-acting
Description:
An levonorgestrel IUS developed by SIPPR.
Updated date:
May 30, 2018
Vertical Tabs
Product Details
Active Pharmaceutical Ingredient (API):
levonorgestrel
Inactive material:
Silicon rubber
Potential Multi-Purpose Technology (MPT):
No
Duration:
5 years
Dose:
30 mg
Partner:
Shanghai Institute of Planned Parenthood Research (SIPPR)
Status
Project Phase:
Early Development
Project Stage:
Pre-clinical
Began discovery in:
2006
Status Details:
The SIPPR product was compared to Mirena in rabbits and found to produce similar LNG plasma concentrations and similar histology in rabbit reproductive organs. Clinical testing in humans is planned.
Programmatic Considerations
Additional Information
Download Product Report
